Tailored Vitamin D Supplementation Improves Normalization Rates

A tailored high-dose oral vitamin D supplementation safely allows a higher proportion of patients to achieve a normalized vitamin D level.
A tailored high-dose oral vitamin D supplementation safely allows a higher proportion of patients to achieve a normalized vitamin D level.

A tailored high-dose oral vitamin D supplementation safely allows a higher proportion of patients to achieve a normalized vitamin D level compared with a conventional regimen in patients with early breast cancer undergoing chemotherapy, a study published in the journal Annals of Oncology has shown.1

Because only a minority of patients with early breast cancer treated with adjuvant or neoadjuvant chemotherapy have sufficient baseline vitamin D levels, researchers sought to evaluate the efficacy and safety of a tailored high-dose oral vitamin D supplementation in normalizing serum vitamin D levels in this patient population.

For the phase 3 trial, researchers enrolled 195 patients with vitamin D deficiency and randomly assigned them 1:1 to receive a 6-month conventional vitamin D and calcium supplementation or a 6-month high-dose oral vitamin D regimen tailored to the individual deficiency plus a conventional calcium supplementation.

Results showed that only 68.4% of patients in the conventional arm and 67% of those in the tailored arm were compliant to the daily oral supplementation, with discontinuous high-dose vitamin D compliance appearing higher in the tailored arm.

Researchers found that 30% of patients in the tailored arm presented with a normalized vitamin D level compared with 12.6% in the conventional arm at 6 months (P = .003).

Furthermore, 52 patients who had not achieved vitamin D normalization after 6 months in the conventional arm switched to the tailored arm, and 44% of those patients achieved vitamin D level normalization.

In terms of safety, supplementation was well tolerated and researchers observed no significant differences in treatment-related toxicity between the 2 groups.

Although the tailored high-dose approach appears to be safe and effective, compliance to a daily oral supplementation regimen remains poor in this treatment setting

REFERENCE

1. Jacot W, Firmin N, Roca L, et al. Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study [published online ahead of print March 30, 2016]. Ann Oncol. doi:10.1093/annonc/mdw145.
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs